1. Home
  2. NKGN vs CHSN Comparison

NKGN vs CHSN Comparison

Compare NKGN & CHSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKGN
  • CHSN
  • Stock Information
  • Founded
  • NKGN 2017
  • CHSN 2009
  • Country
  • NKGN United States
  • CHSN China
  • Employees
  • NKGN N/A
  • CHSN 356
  • Industry
  • NKGN Biotechnology: Biological Products (No Diagnostic Substances)
  • CHSN Packaged Foods
  • Sector
  • NKGN Health Care
  • CHSN Consumer Staples
  • Exchange
  • NKGN Nasdaq
  • CHSN Nasdaq
  • Market Cap
  • NKGN 24.1M
  • CHSN 25.0M
  • IPO Year
  • NKGN N/A
  • CHSN 2023
  • Fundamental
  • Price
  • NKGN $1.17
  • CHSN $1.93
  • Analyst Decision
  • NKGN
  • CHSN
  • Analyst Count
  • NKGN 0
  • CHSN 0
  • Target Price
  • NKGN N/A
  • CHSN N/A
  • AVG Volume (30 Days)
  • NKGN 2.3M
  • CHSN 47.5K
  • Earning Date
  • NKGN 08-16-2024
  • CHSN 08-15-2024
  • Dividend Yield
  • NKGN N/A
  • CHSN N/A
  • EPS Growth
  • NKGN N/A
  • CHSN N/A
  • EPS
  • NKGN N/A
  • CHSN 0.00
  • Revenue
  • NKGN N/A
  • CHSN $17,252,662.00
  • Revenue This Year
  • NKGN N/A
  • CHSN N/A
  • Revenue Next Year
  • NKGN N/A
  • CHSN N/A
  • P/E Ratio
  • NKGN N/A
  • CHSN $656.67
  • Revenue Growth
  • NKGN N/A
  • CHSN 17.44
  • 52 Week Low
  • NKGN $0.78
  • CHSN $1.10
  • 52 Week High
  • NKGN $6.70
  • CHSN $18.65
  • Technical
  • Relative Strength Index (RSI)
  • NKGN 48.72
  • CHSN 36.33
  • Support Level
  • NKGN $0.87
  • CHSN $1.82
  • Resistance Level
  • NKGN $1.36
  • CHSN $2.06
  • Average True Range (ATR)
  • NKGN 0.15
  • CHSN 0.20
  • MACD
  • NKGN 0.02
  • CHSN -0.04
  • Stochastic Oscillator
  • NKGN 59.68
  • CHSN 31.82

About NKGN NKGen Biotech Inc.

NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.

About CHSN Chanson International Holding

Chanson International Holding manufactures and sells a wide selection of bakery products, seasonal products, and beverage products; some of these stores also offer eat-in services. It focuses to make healthy, nutritious, and ready-to-eat food through advanced facilities and industry research and to create a comfortable, yet distinguishable store environment in which customers can enjoy their products.

Share on Social Networks: